SUTERA, Flavia Maria
SUTERA, Flavia Maria
Biomedicina Sperimentale e Neuroscienze Cliniche (attivo dal 01/01/2010 al 31/12/2018)
A new dopamine amino-acid conjugate: preclinical in vitro studies and evaluation of behavioural effects in rats
2012-01-01 Sutera, FM; De Caro, V; Giannola, LI; Scaturro, AL; Plescia, F; Cannizzaro, C; Marino R
A NEW DOPAMINE-AMINOACID CONJUGATE: SYNTHESIS AND DETERMINATION OF PHYSICO-CHEMICAL PROPERTIES USEFUL TO CROSS THE BBB
2012-01-01 Scaturro, AL; Giandalia, G; De Caro, V; Sutera, FM; Gentile, C; Livrea, MA; Cannizzaro, C; Giannola, LI
Acetaldehyde operant self-administration in rats: focus on D2-receptor activation.
2013-01-01 Brancato, A; Marino, RAM; Plescia, F; Sutera, FM; Cannizzaro, C
Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system
2015-01-01 De Caro, V; Scaturro, AL; Di Prima, G; Avellone, G; Sutera, FM; Di Fede, O; Campisi, G; Giannola, LI
Aminoacidic derivatives as novel CNS-targeted neurotherapeutics
2012-01-01 Giandalia, G; De Caro, V; Siragusa, MG; Scaturro, AL; Sutera, FM; Giannola, LI
Assessment of in vivo organ-uptake and in silico prediction of CYP mediated metabolism of DA-Phen, a new dopaminergic agent
2017-01-01 Sutera, F.M.; Giannola, L.I.; Murgia, D.; De Caro, V.
Buccal delivery as a new challenge for treatment of motor fluctuations in Parkinson's Disease
2011-01-01 Giannola, LI; De Caro, V; Giandalia, G; Siragusa, MG; Sutera, FM; Scaturro, AL
Buccal drug delivery: what’s new and what does the future hold?
2014-01-01 Giannola, L.; De Caro, V.; Sutera, F.
Comparative Study of the Effects Exerted by N-Valproyl-L-Phenylalanine and N-valproyl-L-tryptophan on CA1 Hippocampal Epileptiform Activity in Rat.
2018-01-01 Carletti F, Rizzo V, Gambino G, De Caro V, Sutera FM, Giannola LI, Ferraro G, Sardo P.
DA-Phen as a new potential DA-mimetic agent for treatment of alcohol addiction: preclinical in vivo studies
2015-01-01 Sutera, FM; Giunta Cardinale, V; Brancato, A; Vita, C; Plescia, F; Giannola, LI; De Caro, V; Cannizzaro, C
DA-Phen, a new dopamine aminoacid conjugate: in vivo testing and molecular modeling as dopaminergic modulator
2014-01-01 Tutone, M; Almerico, AM; Lauria, A; Sutera, FM; Cannizzaro, C; Giannola, LI; De Caro, V
DESIGN AND CHARACTERIZATION OF MUCOADHESIVE SUBLINGUAL FILMS CONTAINING FUROSEMIDE
2014-01-01 De Caro, V; Ajovalasit, A; Sutera, FM; Scaturro, AL; Sabatino, MA; Dispenza, C; Giannola, LI
Design, synthesis and preliminary evaluation of dopamine-amino acid conjugates as potential D1 dopaminergic modulators
2016-01-01 Tutone, M.; Chinnici, A.; Almerico, A.; Perricone, U.; Sutera, F.; De Caro, V.
Effects of DA-Phen, a dopamine-aminoacidic conjugate, on alcohol intake and forced abstinence
2016-01-01 Sutera, FM.; De Caro, V.; Cannizzaro, C.; Giannola, LI.; Lavanco, G.; Plescia, F.
Evaluation of neuropeptide Y expression during acetaldehyde withdrawal in rats. Focus on hippocampus and nucleus accumbens
2012-01-01 Brancato, A; Plescia, F; Cacace, S; Cappello, F; Venniro, M; Sutera, FM; Cannizzaro, C
In situ delivery of corticosteroids for treatment of oral diseases
2017-01-01 De Caro, V.; Sutera, F.M.; Giannola, L. I.
Is Acetaldehyde a substance of abuse? Evidence from a free-access, three-bottle choice paradigm
2012-01-01 Sutera, FM; Cacace, S; Giannola, LI; De Caro, V; Brancato, A; Cannizzaro, C
Modulation of alcohol consumption using an operant self-administration paradigm: effects of a new dopamine aminoacidic conjugate, Phenylalanine-β(3,4dihydroxyphenyl)-etilamide.
2014-01-01 Sutera, FM; Incandela, G; De Caro, V; Giannola, L; Cannizzaro, C
N-valplroyl-aminoacids as new potential antiepileptic drugs: synthesis, characterization and in vitro studies on stability
2013-01-01 De Caro, V; Scaturro, AL; Sutera, FM; Giannola LI
N-valproyl-aminoacids as new potential antiepileptic drugs: Synthesis, characterization and in vitro studies on stability
2015-01-01 De Caro, V.; Scaturro, A.L.; Sutera, F.M.; Giannola, L.I.